The Michael J. Dunleavy Foundation made its annual contribution to Massachusetts General Hospital on November 4, 2016. The money in part helps support Research into new Technologies in the diagnosis and treatment or Cancers. According to Dr... Howard Weinstein at MGH a New Pilot program is currently being discussed that uses "High Technology devices that can detect rare tumor cells in the blood..." and can "analyze by molecular technologies and potentially provide amazing information about response to therapy and development of resistance without having to biopsy the primary tumor". The Foundation is pleased to help fund this type of research in our goal of helping to fight childhood brain cancers. Your support gives us the ability to continue this fight. Out heart felt thanks go out to all of you that help make this possible.